1 in 4 infants in the intensive care unit likely have a genetic disorder
Infants with genetic disorders often experience a higher risk of mortality, increased
resource utilization, and prolonged hospital stays. For critically ill infants, rapid genome sequencing can enable an early and precise diagnosis, transformingpatient care and improving outcomes.
Transform patient care with rapid genome
sequencing
2x more effective at uncovering genetic conditions than multigene panels
90% of diagnoses made by rapid genome
sequencing would not have been predicted by clinical features alone
Rapid genome is the most powerful diagnostic tool for quickly uncovering a genetic condition in infants.
Genome finds answers that other tests can miss
Implementing rapid genome is proven to:
Change medical management for up to
61% of babies
Reduce healthcare costs up to $15,786 per child
Genome is recommended as a first-line test
The International Precision Child Health Partnership (IPCHiP) recommends genome or exome as a first-line test for NICU patients with
unexplained hypotonia.
8
The American College of Medical Genetics and Genomics (ACMG) recommends genome or exome as a first-line test for developmental
delay, intellectual disability, and congenital anomalies.
10
The National Society of Genetic Counselors (NSGC) recommends genome or exome as a first-line test for all individuals with unexplained
epilepsy and this guideline is endorsed by the American Epilepsy Society (AES).
11
With comprehensive care from start to finish, Orla Health offers more than a test result. Experience the Orla Health difference and help your patients find answers.
Connect with a representative
All fields with asterisk (*) are required
